Zobeida Cruz-Monserrate
Overview
Explore the profile of Zobeida Cruz-Monserrate including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
1954
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramsey M, Lu A, Gumpper-Fedus K, Culp S, Bradley D, Conwell D, et al.
BMC Gastroenterol
. 2025 Feb;
25(1):60.
PMID: 39915752
Background: Sarcopenia is common in chronic pancreatitis (CP) and has been associated with unfavorable outcomes; however, it is not well studied in acute pancreatitis (AP). Aims: To evaluate risk factors...
2.
Park M, Gumpper-Fedus K, Krishna S, Genilo-Delgado M, Brantley S, Hart P, et al.
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684873
Intraductal papillary mucinous neoplasms (IPMN) are commonly detected pancreatic cysts that may transform into pancreatic ductal adenocarcinoma (PDAC). Predicting which IPMNs will progress to PDAC remains a clinical challenge. Moreover,...
3.
Machicado J, Lee P, Culp S, Stello K, Hart P, Ramsey M, et al.
Ann Gastroenterol
. 2024 Nov;
37(6):734-741.
PMID: 39568712
Background: Following endoscopic retrograde cholangiopancreatography (ERCP), post-ERCP pancreatitis (PEP) is the most common complication. The host's innate immune response to periprocedural pancreatic injury is the hallmark of its pathogenesis. Investigating...
4.
Leupold M, Chen W, Esnakula A, Frankel W, Culp S, Hart P, et al.
Gastrointest Endosc
. 2024 Nov;
PMID: 39557199
Background And Aims: Interobserver agreement (IOA) among pancreaticobiliary (PB) pathologists in evaluating high-grade dysplasia and/or invasive carcinoma (HGD-IC) of IPMNs remains understudied. EUS-guided needle-based confocal endomicroscopy (nCLE) can evaluate papillary...
5.
Wang X, He X, Gao T, Zhou X, Cruz-Monserrate Z, Tsung A, et al.
Transl Oncol
. 2024 Sep;
50:102118.
PMID: 39265509
Pancreatic ductal adenocarcinoma (PDAC) poses a formidable challenge in oncology due to its limited treatment options and poor long-term survival rates. Our previous work identified MG53, a member of the...
6.
Akshintala V, Moore M, Cruz-Monserrate Z, Nathan J, Searle B, Abu-El-Haija M
Gastroenterology
. 2024 May;
167(5):1019-1021.e2.
PMID: 38797238
No abstract available.
7.
Pita-Grisanti V, Velez-Bonet E, Chasser K, Hurst Z, Liette A, Vulic G, et al.
Cancer Res
. 2024 May;
84(18):3058-3071.
PMID: 38781455
Obesity is a risk factor for pancreatic ductal adenocarcinoma (PDAC), a deadly disease with limited preventive strategies. Lifestyle interventions to decrease obesity represent a potential approach to prevent obesity-associated PDAC....
8.
Wedig J, Jasani S, Mukherjee D, Lathrop H, Matreja P, Pfau T, et al.
Cancer Immunol Immunother
. 2024 Apr;
73(6):96.
PMID: 38619621
Pancreatic cancer is an aggressive disease with a 5 year survival rate of 13%. This poor survival is attributed, in part, to limited and ineffective treatments for patients with metastatic...
9.
Gumpper-Fedus K, Crowe O, Hart P, Pita-Grisanti V, Velez-Bonet E, Belury M, et al.
Pancreas
. 2024 Mar;
53(5):e416-e423.
PMID: 38530954
Objectives: Chronic pancreatitis (CP) is an inflammatory disease affecting the absorption of fat-soluble nutrients. Signaling in pancreatic cells that lead to inflammation may be influenced by fatty acids (FAs) through...
10.
Gumpper-Fedus K, Chasser K, Pita-Grisanti V, Torok M, Pfau T, Mace T, et al.
Clin Transl Gastroenterol
. 2024 Jan;
15(4):e00686.
PMID: 38284831
Introduction: Chronic pancreatitis (CP) is a progressive fibroinflammatory disorder lacking therapies and biomarkers. Neutrophil gelatinase-associated lipocalin (NGAL) is a proinflammatory cytokine elevated during inflammation that binds fatty acids (FAs) such...